The symposium has been held in Yokohama.

The symposium has been held in Yokohama, From September 15-17 Japan, 2011. Results acquired with ANAVEX 2-73 and ANAVEX1-41 will become outlined by Dr . Tangui Maurice, CNRS Analysis Director, Group II Endogenous Neuroprotection in Neurodegenerative Illnesses INSERM, University of Montpellier. The Anavex presentation will provide an overview of the neuroprotection induced by ligands activating the sigma-1 chaperone proteins in Alzheimer’s disease. Specifically, the pathomimetic toxicity induced by oligomeric amyloid 25-35 fragments injected into the human brain of mice could be alleviated in a number of aspects, including cell loss, cellular stress and brain inflammation.